My current research focus is on developing minimally invasive approaches to the brain and skull base that will result in the best surgical tumor resection possible with the least amount of disruption to normal tissue. Finding a patient treatment option that reduces the amount of long-term consequences for my patients and their families is always my top priority.
Our individualized patient approach, combined with world-renown research methods, make the OSUCCC – James such a fulfilling place for me to work. There are very few places that offer the types of highly specialized surgery we do. That’s why patients come here from all over the world for our uniquely personal and focused care.
My medical journey began in Brazil, where I attended medical school and finished my residency in 2005. I completed fellowships in neuroendocrine and pituitary surgery at the University of Virginia, and another in skull base and cerebrovascular surgery at the University of Pittsburgh. I’m so proud to be part of the OSUCCC – James and believe strongly in our mission to live in a cancer-free world.
Universidade Federal Do Parana
Hospital Nossa Senorah das Grasas
1/1/2001 - 1/31/2005
Additional languages I speak
Specialties and conditions I treat
- Neurological Surgery
- Minimally Invasive Surgical Procedures
- Brain Cancers
- Skull Base Tumors
- Pituitary Cancers
- Cerebrospinal Fluid Rhinorrhea
- Eye Cancers
- Metastasis Cancers
- Nerve Compression Syndromes
- Trigeminal Neuralgia
- Hemifacial Spasm
- Hemangioma, Cavernous, Central Nervous System
- Neuroma, Acoustic
Locations where I practice
More about my work
University of Virginia Medical Center
2/1/2005 - 6/30/2006
UPMC Presbyterian Hospital
8/1/2006 - 6/30/2008
News about me
At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.
As of 03/25/2016, Dr. Prevedello has reported no financial relationships with medical device, research and/or drug companies.